UPDATE 1-GSK gets FDA nod for wider use of ovarian cancer drug Zejula
October 23, 2019 at 20:21 PM EDT
GlaxoSmithKline said U.S. regulators had approved its ovarian cancer treatment Zejula for wider use in some advanced cancers, in a boost to the British drugmaker's oncology portfolio as it competes with rival AstraZeneca.
